COST-EFFECTIVENSS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VS. ANGIOTENSIN II RECEPTOR BLOCKERS AS FIRST-LINE TREATMENT IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

被引：0
|
作者：
Clark, L. A. [1 ]
Whitmire, S. M. [1 ]
Patton, S. [1 ]
Clark, C. A. [1 ]
Blanchette, C. M. [2 ]
机构：
[1] Univ North Carolina Charlotte, Charlotte, NC USA
[2] Univ N Carolina, Charlotte, NC USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PUK14
引用
收藏
页码：A308 / A308
页数：1
相关论文
共 50 条
  • [31] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley A.
    Secora, Alex
    Luo, Shengyuan
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John W.
    Chang, Alex R.
    Grams, Morgan E.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (11) : 2220 - 2229
  • [32] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley
    Secora, Alex
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John
    Chang, Alex
    Grams, Morgan
    CIRCULATION, 2019, 139
  • [33] Prevention of atrial fibrillation by angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers - Reply
    Healey, JS
    Morillo, CA
    Connolly, SJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 890 - 891
  • [34] Which prevents diabetes better: Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Elliott, WJ
    Choi, KL
    Arano, KG
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 57A - 58A
  • [35] Effect of spironolactone combined with angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers on chronic glomerular disease
    Wang, Weisong
    Li, Lihua
    Zhou, Zhonghai
    Gao, Junjie
    Sun, Yinghao
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (06) : 1527 - 1531
  • [36] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport Reply
    Nessim, Sharon J.
    Perl, Jeffrey
    Bargman, Joanne M.
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 137 - 137
  • [37] The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes
    Padwal, Raj
    Lin, Mu
    Eurich, Dean T.
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (03): : 200 - 206
  • [38] Effects of some angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on experimental inflammations
    Magyar, Ioan
    Cret, Mihai
    Cuparencu, Barbu
    FASEB JOURNAL, 2013, 27
  • [39] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization
    Crowley, Matthew J.
    Powers, Benjamin J.
    Myers, Evan R.
    McBroom, Amanda J.
    Sanders, Gillian D.
    AMERICAN HEART JOURNAL, 2012, 163 (05) : 777 - +
  • [40] Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease
    Tiwari, Anjali
    Tseng, Chin-Lin
    Kern, Elizabeth F. O.
    Maney, Miriam
    Miller, Donald R.
    Pogach, Leonard
    AMERICAN JOURNAL OF MANAGED CARE, 2007, 13 (02): : 73 - 79
12345